Floatz logo

Gm-Csf

Pancreatic Cancer, Resected

Zhejiang Provincial People's HospitalPhase 1/2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Pancreatic Cancer, Resected cohort.

Asset / SponsorPhaseRating
tg01
Targovax ASA
Phase 1/2CCC
FUROSEMIDE
Tribhuvan University Teaching Hospital, Institute Of Medicine.
N/AD

Same molecule, other indications

Gm-Csf is also rated in:

melanomaDormant
BBB
Indicative ·
74 / 100
View asset →
acute lymphoblastic leukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
uveal melanomaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →